Genetic variation and lipid metabolism: Modulation by dietary factors

Current Cardiology Reports

Volumn 7, Issue 6, 2005, Pages 480-486

  Ordovas, Jose M ^a   Corella, Dolores ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; EATING HABIT; GENE LOCUS; GENETIC VARIABILITY; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MOLECULAR INTERACTION; MOLECULAR MECHANICS; POSTPRANDIAL STATE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 28244492319     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-005-0067-6     Document Type: Review

References (49)

1. Breslow JL: Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu Rev Genet 2000, 34:233-254.
2. Lusis AJ, Mar R, Pajukanta P: Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 2004, 5:189-218.
3. Ordovas JM: HDL genetics: candidate genes, genome wide scans and gene-environment interactions. Cardiovasc Drugs Ther 2002, 16:273-281.
4. Ordovas JM, Mooser V: The APOE locus and the pharmacogenetics of lipid response. Curr Opin Lipidol 2002, 13:113-117.
5. Ordovas JM: Genetic polymorphisms and activity of cholesterol ester transfer protein(CETP): should we be measuring them? Clin Chem Lab Med 2000, 38:945-949.
6. Humphries SE, Montgomery HE, Talmud PJ: Predisposing genes, high-risk environments and coronary artery disease: LPL and fibrinogen as examples. World Rev Nutr Diet 2001, 89:61-67.
7. Pennacchio LA, Rubin EM: Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 2003, 23:529-534.
8. Ottman R: An epidemiological approach to gene-environment interaction. Genet Epidemiol 1990, 7:177-185.
9. Kardia SL: Context-dependent genetic effects in hypertension. Curr Hypertens Rep 2000, 2:32-38.
10. Holtzman NA: Genetic variation in nutritional requirements and susceptibility to disease: policy implications. Am J Clin Nutr 1988, 48:1510-1516.
11. Jacobs DR Jr, Anderson JT, Hannan P, et al.: Variability in individual serum cholesterol response to change in diet. Arteriosclerosis 1983, 3:349-356.
12. Katan MB, Beynen AC, De Vries JH, Nobels A: Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol 1986, 123:221-234.
13. Katan MB, Grundy SM, Willett WC: Should a low-fat, high-carbohydrate diet be recommended for everyone? Beyond low-fat diets. N Engl J Med 1997, 337:563-566.
14. Krauss RM: Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu Rev Nutr 2001, 21:283-295.
15. Jacobs B, De Angelis-Schierbaum G, Egert S, et al.: Individual serum triglyceride responses to high-fat and low-fat diets differ in men with modest and severe hypertriglyceridemia. J Nutr 2004, 134:1400-1405.
16. Parks EJ, Rutledge JC, Davis PA, et al.: Predictors of plasma triglyceride elevation in patients participating in a coronary atherosclerosis treatment program. J Cardiopulm Rehabil 2001, 21:73-79.
17. Loktionov A: Common gene polymorphisms and nutrition: emerging links with pathogenesis of multifactorial chronic diseases. J Nutr Biochem 2003, 14:426-451.
18. Jansen AC, van Wissen S, Defesche JC, Kastelein JJ: Phenotypic variability in familial hypercholesterolaemia: an update. Curr Opin Lipidol 2002, 13:165-171.
19. Bertolini S, Pisciotta L, Di Scala L, et al.: Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis 2004, 174:57-65.
20. Williams RR, Hasstedt SJ, Wilson DE, et al.: Evidence that men with familial hypercholesterolemia can avoid early coronary death. An analysis of 77 gene carriers in four Utah pedigrees. JAMA 1986, 255:219-224.
21. Sijbrands EJ, Westendorp RG, Defesche JC, et al.: Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 2001, 322:1019-1023.
22. Pimstone SN, Sun XM, du Souich C, et al.: Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler Thromb Vasc Biol 1998, 18:309-315.
23. Sun XM, Patel DD, Webb JC, et al.: Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler Thromb 1994, 14:85-94.
24. Poustie VJ, Rutherford P: Dietary treatment for familial hypercholesterolaemia. Cochrane Database Syst Rev 2001, 2:CD001918.
25. Civeira F, International Panel on Management of Familial Hypercholesterolemia: Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 2004, 173:55-68.
26. Masson LF, McNeill G, Avenell A: Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 2003, 77:1098-1111.
27. Corella D, Ordovas JM: Single Nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr 2004, 5:71-118.
28. Ordovas JM, Corella D: Genes, diet and plasma lipids: the evidence from observational studies. World Rev Nutr Diet 2004, 93:41-76.
29. Ordovas JM, Corella D: Nutritional genomics. Annu Rev Genomics Hum Genet 2004, 5:71-118.
30. Moreno JA, Perez-Jimenez F, Marin C, et al.: Apolipoprotein E gene promoter -219G->T polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat. Am J Clin Nutr 2004, 80:1404-1409.
31. Kovar J, Suchanek P, Hubacek JA, Poledne R: The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiol Res 2004, 53:565-568.
32. Hofman MK, Weggemans RM, Zock PL, et al.: CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans. J Nutr 2004, 134:2200-2204.
33. Markovic O, O'Reilly G, Fussell HM, et al.: Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males. Clin Nutr 2004, 23:1084-1095.
34. Paradis AM, Fontaine-Bisson B, Bosse Y, et al.: The peroxisome proliferator-activated receptor alpha Leu 162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. Am J Clin Nutr 2005, 81:523-530.
35. Perez-Martinez P, Perez-Jimenez F, Bellido C, et al.: A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet. J Clin Endocrinol Metab 2005, 90:2297-2300.
36. Paschos GK, Yiannakouris N, Rallidis LS, et al.: Apolipoprotein E genotype in dyslipidemic patients and response of blood lipids and inflammatory markers to alpha-linolenic Acid. Angiology 2005, 56:49-60.
37. Jemaa R, Mebazaa A, Fumeron F: Apolipoprotein B signal peptide polymorphism and plasma LDL-cholesterol response to low-calorie diet. Int J Obes Relat Metab Disord 2004, 28:902-905.
38. Tobin MD, Minelli C, Burton PR, et al.: Development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding'. Int J Epidemiol 2004, 33:26-29.
39. Tai ES, Corella D, Demissie S, et al.: Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr 2005, 135:397-403.
40. Olivieri O, Martinelli N, Sandri M, et al.: Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction. Clin Chem 2005, 51:360-367.
41. Robitaille J, Brouillette C, Lemieux S, et al.: Plasma concentrations of apolipoprotein B are modulated by a gene - diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol Genet Metab 2004, 82:296-303.
42. Lee J, Tan CS, Chia KS, et al.: The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption. J Lipid Res 2004, 45:1132-1139.
43. Dwyer JH, Allayee H, Dwyer KM, et al.: Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004, 350:29-37.
44. Ordovas JM: Genetics, postprandial lipemia and obesity. Nutr Metab Cardiovasc Dis 2001, 11:118-133.
45. Zilversmit DB: Atherogenesis: a postprandial phenomenon. Circulation 1979, 60:473-485.
46. Dworatzek PD, Hegele RA, Wolever TM: Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. Am J Clin Nutr 2004, 79:1110-1117.
47. Lopez-Miranda J, Cruz G, Gomez P, et al.: The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism. J Clin Endocrinol Metab 2004, 89:4721-4728.
48. Perez-Martinez P, Lopez-Miranda J, Ordovas JM, et al.: Postprandial lipemia is modified by the presence of the polymorphism present in the exon 1 variant at the SR-BI gene locus. J Mol Endocrinol 2004, 32:237-245.
49. van Ommen B, Stierum R: Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr Opin Biotechnol 2002, 13:517-521.